Adding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) time for patients with advanced biliary tract cancers, although ...
In the May 1, 2005, issue of the Journal of Clinical Oncology, D'Addario et al 1 reported on a meta-analysis designed to compare the efficacy and toxicity of platinum-based with non–platinum-based ...
Predictive Impact of 2-18Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography for Residual Postchemotherapy Masses in Patients With Bulky Seminoma PURPOSE: Most anticancer drugs are dosed based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback